Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
AXIM Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: December 23, 2024
Report Source: 2024 2nd Quarter Report
Axim Biotechnologies Inc. Stock Analysis AXIM
United States Health Care Nano Cap Report: AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. The company is headquartered in San Diego, California and currently employs 6 full-time employees. The company went IPO on 2013-04-09. The firm's TearScan platform enables clinicians to quantify tear biomarkers with laboratory-grade accuracy in office settings, enhancing diagnostic confidence and treatment outcomes. The firm's product portfolio falls under the Eye Health sector and consists of the two FDA cleared 510(k) tests for dry eye disease (DED) and allergic conjunctivitis, both testing tears for these diseases. The company has also internally developed an immunoassay for a potential third product which would measure MMP-9 in tears. MMP-9 is a biomarker for ocular surface inflammation and is an additional diagnostic tool for DED and other eye diseases. Its ophthalmological diagnostic tests include Ocular Immunoglobulin E (IgE) Test and Lactoferrin Test. IgE is a biomarker for allergic conjunctivitis, which often mimics dry eye disease or co-exists with dry eye disease.
Read More Axim Biotechnologies Inc (AXIM) Chart
Key Statistics of Axim Biotechnologies Inc (AXIM)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
13.13KP/E Ratio (TTM)
-52 Week Range
Market Cap
2.00MAvg. Volume
90.54KDividend Yield
-Financial Metrics & Statements of Axim Biotechnologies Inc (AXIM)
FAQ's for Axim Biotechnologies Inc (AXIM)
- According to Musaffa’s Shariah screening methodology, Axim Biotechnologies Inc (AXIM) is currently classified as NOT HALAL as of December 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Axim Biotechnologies Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Axim Biotechnologies Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Axim Biotechnologies Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Axim Biotechnologies Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Axim Biotechnologies Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.